Literature DB >> 25620816

Neuropsychiatric Symptoms in Lupus.

Maria Gulinello1, Jing Wen2, Chaim Putterman3.   

Abstract

Entities:  

Year:  2012        PMID: 25620816      PMCID: PMC4302271          DOI: 10.3928/00485713-20120906-05

Source DB:  PubMed          Journal:  Psychiatr Ann        ISSN: 0048-5713


× No keyword cloud information.
  79 in total

1.  Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; B Estañol; G García-Ramos; A R Villa
Journal:  Ann N Y Acad Sci       Date:  1997-08-14       Impact factor: 5.691

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  The role of endothelial dysfunction in the pathogenesis of neuropsychiatric systemic lupus erythematosus.

Authors:  R Davey; J Bamford; P Emery
Journal:  Lupus       Date:  2010-01-29       Impact factor: 2.911

4.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

5.  Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

Authors:  S Hirohata; S Hirose; T Miyamoto
Journal:  Arch Intern Med       Date:  1985-10

Review 6.  Evidence for a cytokine model of cognitive function.

Authors:  J McAfoose; B T Baune
Journal:  Neurosci Biobehav Rev       Date:  2008-10-18       Impact factor: 8.989

7.  Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Authors:  Aric A Prather; Mordechai Rabinovitz; Bruce G Pollock; Francis E Lotrich
Journal:  Brain Behav Immun       Date:  2009-07-15       Impact factor: 7.217

Review 8.  Neuropsychiatric complications of interferons: classification, neurochemical bases, and management.

Authors:  Parviz Malek-Ahmadi; Robin C Hilsabeck
Journal:  Ann Clin Psychiatry       Date:  2007 Apr-Jun       Impact factor: 1.567

9.  Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; L Su; S-C Bae; C Gordon; A Clarke; S Bernatsky; A Vasudevan; D Isenberg; A Rahman; D J Wallace; P R Fortin; D Gladman; J Romero-Diaz; J Romero-Dirz; J Sanchez-Guerrero; M A Dooley; I Bruce; K Steinsson; M Khamashta; S Manzi; R Ramsey-Goldman; G Sturfelt; O Nived; R van Vollenhoven; M Ramos-Casals; C Aranow; M Mackay; K Kalunian; G S Alarcón; B J Fessler; G Ruiz-Irastorza; M Petri; S Lim; D Kamen; C Peschken; V Farewell; K Thompson; C Theriault; J T Merrill
Journal:  Ann Rheum Dis       Date:  2011-10       Impact factor: 19.103

10.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

View more
  8 in total

1.  Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.

Authors:  Sivan Gelb; Ariel D Stock; Shira Anzi; Chaim Putterman; Ayal Ben-Zvi
Journal:  J Autoimmun       Date:  2018-04-04       Impact factor: 7.094

2.  Dynamic Contrast-Enhanced MRI Reveals Unique Blood-Brain Barrier Permeability Characteristics in the Hippocampus in the Normal Brain.

Authors:  J Ivanidze; M Mackay; A Hoang; J M Chi; K Cheng; C Aranow; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-07       Impact factor: 3.825

Review 3.  Inflammation and the Central Nervous System in Inflammatory Rheumatic Disease.

Authors:  Chelsea Kaplan; Alexa Minc; Neil Basu; Andrew Schrepf
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

4.  Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.

Authors:  J M Chi; M Mackay; A Hoang; K Cheng; C Aranow; J Ivanidze; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-21       Impact factor: 3.825

5.  Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus.

Authors:  Li Lu; Wei Kong; Kangxing Zhou; Jinglei Chen; Yayi Hou; Huan Dou; Jun Liang
Journal:  BMC Rheumatol       Date:  2021-06-09

6.  B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.

Authors:  Jing Wen; Jessica Doerner; Samantha Chalmers; Ariel Stock; Haowei Wang; Maria Gullinello; Mark J Shlomchik; Chaim Putterman
Journal:  J Neuroinflammation       Date:  2016-04-07       Impact factor: 8.322

7.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

8.  A Novel Microglia-Specific Transcriptional Signature Correlates With Behavioral Deficits in Neuropsychiatric Lupus.

Authors:  Hadijat M Makinde; Deborah R Winter; Daniele Procissi; Elise V Mike; Ariel D Stock; Mary J Kando; Gaurav T Gadhvi; Steven Droho; Christina L Bloomfield; Salina T Dominguez; Maximilian G Mayr; Jeremy A Lavine; Chaim Putterman; Carla M Cuda
Journal:  Front Immunol       Date:  2020-02-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.